东盟成员国在癌症诊断可及性方面的差异。
Disparities in access to cancer diagnostics in ASEAN member countries.
作者信息
Alberto Nicole Rose I, Alberto Isabelle Rose I, Puyat Corinna Victoria M, Antonio Maria Alexandra R, Ho Frances Dominique V, Dee Edward Christopher, Mahal Brandon A, Eala Michelle Ann B
机构信息
College of Medicine, University of the Philippines, Manila, Philippines.
Ateneo School of Medicine and Public Health, Pasig City, Philippines.
出版信息
Lancet Reg Health West Pac. 2023 Jan 6;32:100667. doi: 10.1016/j.lanwpc.2022.100667. eCollection 2023 Mar.
Diagnostics, including laboratory tests, medical and nuclear imaging, and molecular testing, are essential in the diagnosis and management of cancer to optimize clinical outcomes. With the continuous rise in cancer mortality and morbidity in the Association of Southeast Asian Nations (ASEAN), there exists a critical need to evaluate the accessibility of cancer diagnostics in the region so as to direct multifaceted interventions that will address regional inequities and inadequacies in cancer care. This paper identifies existing gaps in service delivery, health workforce, health information systems, leadership and governance, and financing and how these contribute to disparities in access to cancer diagnostics in ASEAN member countries. Intersectoral health policies that will strengthen coordinated laboratory services, upscale infrastructure development, encourage health workforce production, and enable proper appropriation of funding are necessary to effectively reduce the regional cancer burden.
诊断方法，包括实验室检查、医学影像和核医学影像以及分子检测，对于癌症的诊断和管理以优化临床结果至关重要。随着东南亚国家联盟（东盟）地区癌症死亡率和发病率的持续上升，迫切需要评估该地区癌症诊断方法的可及性，以便指导多方面的干预措施，解决癌症护理方面的地区不平等和不足问题。本文确定了在服务提供、卫生人力、卫生信息系统、领导与治理以及筹资方面存在的现有差距，以及这些差距如何导致东盟成员国在获得癌症诊断方法方面的差异。加强协调实验室服务、提升基础设施发展、鼓励卫生人力培养以及实现资金的合理分配的跨部门卫生政策，对于有效减轻该地区的癌症负担是必要的。
Zotero 插件